nach oben

Metabolic Brain Disease

Erschienen in:

26.12.2017 | Original Article

Trigonelline insulates against oxidative stress, proinflammatory cytokines and restores BDNF levels in lipopolysaccharide induced cognitive impairment in adult mice

verfasst von: Amrita A. Chowdhury, Nitin B. Gawali, Renuka Munshi, Archana R. Juvekar

Erschienen in: Metabolic Brain Disease | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Neuroinflammation is said to play a pivotal role in the pathogenesis of neurodegenerative disorders such as Alzheimer’s disease (AD). Trigonelline (TRG) is a naturally occurring alkaloid, commonly isolated from fenugreek and coffee beans. In the present study, we investigated whether TRG exerts neuroprotective action against LPS mediated cognitive impairment. Mice pretreated with TRG (50 and 100 mg/kg po) were administered with LPS (250 μg/kg ip) for 7 days. Memory was assessed in the Morris water maze (MWM) and Y maze. LPS administration caused poor memory retention in MWM and Y maze paradigms, and resulted in marked oxidative stress as evidenced by decrease in superoxide dismutase (SOD), reduced glutathione (GSH) levels and increased lipid peroxidation in the hippocampus and cortex. Cholinergic involvement during neuroinflammation was evaluated by measuring levels of acetylcholinesterase (AChE) enzyme. TRG treatment at both the doses reversed LPS induced behavioral and memory disturbances, significantly decreased the oxidative stress and AChE levels in both the hippocampus and cortex. LPS administration also elevated the tumour necrosis factor (TNF-α) and interleukin −6 (IL-6) levels, whereas brain derived neurotrophic factor (BDNF) levels were significantly depleted. TRG pretreatment led to decreased TNF-α and IL-6 levels and caused a significant upregulation of BDNF levels. In conclusion, present study highlights the promising neuroprotective role of TRG against LPS mediated cognitive impairment which could be attributed to reduced oxidative stress, inhibition of proinflammatory cytokines and restoration of BDNF levels.

Aldakinah AAA, Al-Shorbagy MY, Abdallah DM, El-Abhar HS (2017) Trigonelline and vildagliptin antidiabetic effect: improvement of insulin signalling pathway. J Pharm Pharmacol 69(7):856–864. https://doi.org/10.1111/jphp.12713 CrossRefPubMed

Antonisamy P, Arasu MV, Dhanasekaran M, Choi KC, Aravinthan A, Kim NS, Kang C-W, Kim J-H (2016) Protective effects of trigonelline against indomethacin-induced gastric ulcer in rats and potential underlying mechanisms. Food Funct 7(1):398–408. https://doi.org/10.1039/C5FO00403A CrossRefPubMed

Arlt A, Sebens S, Krebs S, Geismann C, Grossmann M, Kruse M, Schreiber S, Schäfer H (2013) Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity. Oncogene 32(40):4825–4835. https://doi.org/10.1038/onc.2012.493 CrossRefPubMed

Association, A. s (2016) 2016 Alzheimer's disease facts and figures. Alzheimers Dement 12(4):459–509. https://doi.org/10.1016/j.jalz.2016.03.001 CrossRef

Badshah H, Ali T, Kim MO (2016) Osmotin attenuates LPS-induced neuroinflammation and memory impairments via the TLR4/NFκB signaling pathway. Sci Rep 6(1):24493. https://doi.org/10.1038/srep24493 CrossRefPubMedPubMedCentral

Choi D-Y, Lee JW, Lin G, Lee YK, Lee YH, Choi IS, Han SB, Jung JK, Kim YH, Kim KH (2012) Obovatol attenuates LPS-induced memory impairments in mice via inhibition of NF-κB signaling pathway. Neurochem Int 60(1):68–77. https://doi.org/10.1016/j.neuint.2011.11.005 CrossRefPubMed

Chowdhury AA, Gawali NB, Bulani VD, Kothavade PS, Mestry SN, Deshpande PS, Juvekar AR (2017) In vitro antiglycating effect and in vivo neuroprotective activity of Trigonelline in D-galactose induced cognitive impairment. Pharmacol Rep. https://doi.org/10.1016/j.pharep.2017.09.006

Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nature. Rev Neurosci 9(1):46–56. https://doi.org/10.1038/nrn2297 CrossRef

Deng X, Meili Li WA, He L, Lu D, Patrylo PR, Cai H, Luo X, Li Z, Yan X (2014) Lipolysaccharide-induced neuroinflammation is associated with Alzheimer-like amyloidogenic axonal pathology and dendritic degeneration in rats. Adv Alzheimer Dis 3(2):78–93. https://doi.org/10.4236/aad.2014.32009 CrossRefPubMedPubMedCentral

Ellman GL, Courtney KD, Andres V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7(2):88–95. https://doi.org/10.1016/0006-2952(61)90145-9 CrossRefPubMed

García-Ayllón M-S, Small DH, Avila J, Sáez-Valero J (2011) Revisiting the role of acetylcholinesterase in Alzheimer’s disease: cross-talk with P-tau and β-amyloid. Front Mol Neurosci 4. https://doi.org/10.3389/fnmol.2011.00022

Gaur V, Bodhankar SL, Mohan V, Thakurdesai PA (2013) Neurobehavioral assessment of hydroalcoholic extract of Trigonella Foenum-Graecum seeds in rodent models of Parkinson’s disease. Pharm Biol 51(5):550–557. https://doi.org/10.3109/13880209.2012.747547 CrossRefPubMed

Ghezzi P, Sacco S, Agnello D, Marullo A, Caselli G, Bertini R (2000) LPS induces IL-6 in the brain and in serum largely through TNF production. Cytokine 12(8):1205–1210. https://doi.org/10.1006/cyto.2000.0697 CrossRefPubMed

Gong Q-H, Wang Q, Pan L-L, Liu X-H, Huang H, Zhu Y-Z (2010) Hydrogen sulfide attenuates lipopolysaccharide-induced cognitive impairment: a pro-inflammatory pathway in rats. Pharmacol Biochem Behav 96(1):52–58. https://doi.org/10.1016/j.pbb.2010.04.006 CrossRefPubMed

Gonzalez-Scarano F, Baltuch G (1999) Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 22(1):219–240. https://doi.org/10.1146/annurev.neuro.22.1.219 CrossRefPubMed

Gornall AG, Bardawill CJ, David MM (1949) Determination of serum proteins by means of the biuret reaction. J Biol Chem 177(2):751–766PubMed

Götz J, Ittner LM (2008) Animal models of Alzheimer's disease and frontotemporal dementia. Nature. Rev Neurosci 9(7):532–544. https://doi.org/10.1038/nrn2420 CrossRef

Guan Z, Fang J (2006) Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats. Brain Behav Immun 20(1):64–71. https://doi.org/10.1016/j.bbi.2005.04.005 CrossRefPubMed

Hauss-Wegrzyniak B, Lukovic L, Bigaud M, Stoeckel M (1998) Brain inflammatory response induced by intracerebroventricular infusion of lipopolysaccharide: an immunohistochemical study. Brain Res 794(2):211–224. https://doi.org/10.1016/S0006-8993(98)00227-3 CrossRefPubMed

Helmy AA, Naseer MMA, El Shafie S, Nada MA (2012) Role of interleukin 6 and alpha-globulins in differentiating Alzheimer and vascular dementias. Neurodegener Dis 9(2):81–86. https://doi.org/10.1159/000329568 CrossRefPubMed

Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM (2015) Neuroinflammation in Alzheimer's disease. Lancet Neurol 14(4):388–405. https://doi.org/10.1016/S1474-4422(15)70016-5 CrossRefPubMedPubMedCentral

Heppner FL, Ransohoff RM, Becher B (2015) Immune attack: the role of inflammation in Alzheimer disease. Nature. Rev Neurosci 16(6):358–372. https://doi.org/10.1038/nrn3880 CrossRef

Hickman SE, Allison EK, El Khoury J (2008) Microglial dysfunction and defective β-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci 28(33):8354–8360. https://doi.org/10.1523/JNEUROSCI.0616-08.2008 CrossRefPubMedPubMedCentral

Hock C, Heese K, Hulette C, Rosenberg C, Otten U (2000) Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol 57(6):846–851. https://doi.org/10.1001/archneur.57.6.846 CrossRefPubMed

Hong BN, Yi TH, Park R, Kim SY, Kang TH (2008) Coffee improves auditory neuropathy in diabetic mice. Neurosci Lett 441(3):302–306. https://doi.org/10.1016/j.neulet.2008.06.049 CrossRefPubMed

Hou Y, Xie G, Miao F, Ding L, Mou Y, Wang L, Su G, Chen G, Yang J, Wu C (2014) Pterostilbene attenuates lipopolysaccharide-induced learning and memory impairment possibly via inhibiting microglia activation and protecting neuronal injury in mice. Prog Neuro-Psychopharmacol Biol Psychiatry 54:92–102. https://doi.org/10.1016/j.pnpbp.2014.03.015 CrossRef

Ilavenil S, Arasu MV, Lee J-C, Kim DH, Roh SG, Park HS, Choi GJ, Mayakrishnan V, Choi KC (2014) Trigonelline attenuates the adipocyte differentiation and lipid accumulation in 3T3-L1 cells. Phytomedicine 21(5):758–765. https://doi.org/10.1016/j.phymed.2013.11.007 CrossRefPubMed

Inestrosa NC, Alvarez A, Pérez CA, Moreno RD, Vicente M, Linker C, Casanueva OI, Soto C, Garrido J (1996) Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron 16(4):881–891. https://doi.org/10.1016/S0896-6273(00)80108-7 CrossRefPubMed

Ittner LM, Götz J (2011) Amyloid-β and tau—a toxic pas de deux in Alzheimer's disease. Nature. Rev Neurosci 12(2):67–72CrossRef

Jang YJ, Kim J, Shim J, Kim C-Y, Jang J-H, Lee KW, Lee HJ (2013) Decaffeinated coffee prevents scopolamine-induced memory impairment in rats. Behav Brain Res 245:113–119. https://doi.org/10.1016/j.bbr.2013.02.003 CrossRefPubMed

Jiang T, Sun Q, Chen S (2016) Oxidative stress: a major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease. Prog Neurobiol 147:1–19. https://doi.org/10.1016/j.pneurobio.2016.07.005 CrossRefPubMed

Joshi R, Garabadu D, Teja GR, Krishnamurthy S (2014) Silibinin ameliorates LPS-induced memory deficits in experimental animals. Neurobiol Learn Mem 116:117–131. https://doi.org/10.1016/j.nlm.2014.09.006 CrossRefPubMed

Kamble HV, Bodhankar SL (2013) Antihyperglycemic activity of trigonelline and sitagliptin in nicotinamide-streptozotocin induced diabetes in Wistar rats. Biomedicine & Aging Pathology 3(3):125–130. https://doi.org/10.1016/j.biomag.2013.05.006 CrossRef

Kirsten TB, Galvão MC, Reis-Silva TM, Queiroz-Hazarbassanov N, Bernardi MM (2015) Zinc prevents sickness behavior in duced by lipopolysaccharides after a stress challenge in rats. PLoS One 10(3):e0120263. https://doi.org/10.1371/journal.pone.0120263 CrossRefPubMedPubMedCentral

Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM (2005) Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J Neurosci 25(39):8843–8853. https://doi.org/10.1523/JNEUROSCI.2868-05.2005 CrossRefPubMed

Koenigsknecht-Talboo J, Landreth GE (2005) Microglial phagocytosis induced by fibrillar β-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J Neurosci 25(36):8240–8249. https://doi.org/10.1523/JNEUROSCI.1808-05.2005 CrossRefPubMed

Krabbe G, Halle A, Matyash V, Rinnenthal JL, Eom GD, Bernhardt U, Miller KR, Prokop S, Kettenmann H, Heppner FL (2013) Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS One 8(4):e60921. https://doi.org/10.1371/journal.pone.0060921 CrossRefPubMedPubMedCentral

Ma M, Chen Y, He J, Zeng T, Wang J (2007) Effects of morphine and its withdrawal on Y-maze spatial recognition memory in mice. Neuroscience 147(4):1059–1065. https://doi.org/10.1016/j.neuroscience.2007.05.020 CrossRefPubMed

Ma L, Zhang H, Liu N, Wang PQ et al (2016) TSPO ligand PK11195 alleviates neuroinflammation and beta-amyloid generation induced by systemic LPS administration. Brain Res. Bull 121:192–200CrossRefPubMed

Mayakrishnan T, Nakkala JR, Jeepipalli SPK, Raja K, Chandra VK, Mohan VK, Sadras SR (2014) Fenugreek seed extract and its phytocompounds-trigonelline and diosgenin arbitrate their hepatoprotective effects through attenuation of endoplasmic reticulum stress and oxidative stress in type 2 diabetic rats. Eur Food Res Technol 240(1):223–232CrossRef

McCaulley ME, Grush KA (2015) Alzheimer’s disease: exploring the role of inflammation and implications for treatment. Int J Alzheimers dis. 2015. Article ID 515248

Nandi A, Chatterjee I (1988) Assay of superoxide dismutase activity in animal tissues. J Biosci 13(3):305–315. https://doi.org/10.1007/BF02712155 CrossRef

Noworyta-Sokołowska K, Górska A, Gołembiowska K (2013) LPS-induced oxidative stress and inflammatory reaction in the rat striatum. Pharmacol Rep 65(4):863–869. https://doi.org/10.1016/S1734-1140(13)71067-3 CrossRefPubMed

Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95(2):351–335. https://doi.org/10.1016/0003-2697(79)90738-3 CrossRefPubMed

Panda S, Biswas S, Kar A (2013) Trigonelline isolated from fenugreek seed protects against isoproterenol-induced myocardial injury through down-regulation of Hsp27 and αB-crystallin. Nutrition 29(11):1395–1403. https://doi.org/10.1016/j.nut.2013.05.006 CrossRefPubMed

Patel NS, Paris D, Mathura V, Quadros AN, Crawford FC, Mullan MJ (2005) Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease. J Neuroinflammation 2(1):9. https://doi.org/10.1186/1742-2094-2-9 CrossRefPubMedPubMedCentral

Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, Winslow JW (1991) BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 7(5):695–702. https://doi.org/10.1016/0896-6273(91)90273-3 CrossRefPubMed

Prince MJ (2015) World Alzheimer Report 2015: the global impact of dementia: an analysis of prevalence, incidence, cost and trends. Alzheimer’s Disease International, London

Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT (2007) Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55(5):453–462. https://doi.org/10.1002/glia.20467 CrossRefPubMedPubMedCentral

Satheeshkumar N, Mukherjee PK, Bhadra S, Saha B (2010) Acetylcholinesterase enzyme inhibitory potential of standardized extract of Trigonella foenum graecum L and its constituents. Phytomedicine 17(3):292–295. https://doi.org/10.1016/j.phymed.2009.06.006 CrossRefPubMed

Singh M, Kaur M, Kukreja H, Chugh R, Silakari O, Singh D (2013) Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection. Eur. J. Med Chem 70:165–188

Smith IK, Vierheller TL, Thorne CA (1988) Assay of glutathione reductase in crude tissue homogenates using 5, 5′-dithiobis (2-nitrobenzoic acid). Anal Biochem 175(2):408–413. https://doi.org/10.1016/0003-2697(88)90564-7 CrossRefPubMed

Tanila H (2017) The role of BDNF in Alzheimer's disease. Neurobiol Dis 97(Pt B):114–118CrossRefPubMed

Tharaheswari M, Reddy NJ, Kumar R, Varshney K, Kannan M, Rani SS (2014) Trigonelline and diosgenin attenuate ER stress, oxidative stress-mediated damage in pancreas and enhance adipose tissue PPARγ activity in type 2 diabetic rats. Mol Cell Biochem 396(1–2):161–174. https://doi.org/10.1007/s11010-014-2152-x CrossRefPubMed

Tohda C, Nakamura N, Komatsu K, Hattori M (1999) Trigonelline-induced neurite outgrowth in human neuroblastoma SK-N-SH cells. Biol Pharm Bull 22(7):679–682. https://doi.org/10.1248/bpb.22.679 CrossRefPubMed

Tohda C, Kuboyama T, Komatsu K (2005) Search for natural products related to regeneration of the neuronal network. Neurosignals 14(1–2):34–45. https://doi.org/10.1159/000085384 CrossRefPubMed

Wang W-Y, Tan M-S, Yu J-T, Tan L (2015) Role of pro-inflammatory cytokines released from microglia in Alzheimer’s disease. Ann Transl Med 3(10):136. https://doi.org/10.3978/j.issn.2305-5839.2015.03.49 PubMedPubMedCentralCrossRef

Wei P, Liu Q, Li D, Zheng Q, Zhou J, Li J (2015) Acute nicotine treatment attenuates lipopolysaccharide-induced cognitive dysfunction by increasing BDNF expression and inhibiting neuroinflammation in the rat hippocampus. Neurosci Lett 604:161–166. https://doi.org/10.1016/j.neulet.2015.08.008 CrossRefPubMed

Xiao S, Wang T, Ma X, Qin Y, Li X, Zhao Z, Liu X, Wang X, Xie H, Jiang Q (2017) Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a phase II multicenter randomised controlled trial. Age Ageing:1–7

Yoshinari O, Takenake A, Igarashi K (2013) Trigonelline ameliorates oxidative stress in type 2 diabetic Goto-Kakizaki rats. J Med Food 16(1):34–41. https://doi.org/10.1089/jmf.2012.2311 CrossRefPubMed

Zhang D-F, Zhang F, Zhang J, Zhang R-M, Li R (2015) Protection effect of trigonelline on liver of rats with non-alcoholic fatty liver diseases. Asian Pac J. Trop Biomed 8(8):651–654

Titel: Trigonelline insulates against oxidative stress, proinflammatory cytokines and restores BDNF levels in lipopolysaccharide induced cognitive impairment in adult mice
verfasst von: Amrita A. Chowdhury
Nitin B. Gawali
Renuka Munshi
Archana R. Juvekar
Publikationsdatum: 26.12.2017
Verlag: Springer US
Erschienen in: Metabolic Brain Disease / Ausgabe 3/2018
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-017-0147-5

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Trigonelline insulates against oxidative stress, proinflammatory cytokines and restores BDNF levels in lipopolysaccharide induced cognitive impairment in adult mice

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Wartezeit nicht kürzer, aber Arbeit flexibler

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Ethanol extract of Rehmannia glutinosa exerts antidepressant-like effects on a rat chronic unpredictable mild stress model by involving monoamines and BDNF

Serum ischemia modified albumin is a possible new marker of oxidative stress in phenylketonuria

Methylphenidate disrupts cytoskeletal homeostasis and reduces membrane-associated lipid content in juvenile rat hippocampus

Anticonvulsive effects of endocannabinoids; an investigation to determine the role of regulatory components of endocannabinoid metabolism in the Pentylenetetrazol induced tonic- clonic seizures

The possible factors affecting microglial activation in cases of obesity with cognitive dysfunction

Cardiovascular profile improvement during Natalizumab treatment

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Wartezeit nicht kürzer, aber Arbeit flexibler

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

Update Neurologie